Stay updated with breaking news from Shik Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
01.05.2024 - BURLINGTON, Mass., May 01, 2024 (GLOBE NEWSWIRE) - Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported ...
Highly selective oral SMARCA2 degrader, PRT7732, shows robust anti-tumor activity in vivo as monotherapy and in combination with chemotherapy, at...
Highly selective oral SMARCA2 degrader, PRT7732, shows robust anti-tumor activity in vivo as monotherapy and in combination with chemotherapy, at well-tolerated doses Potentially best-in-class CDK9...
WILMINGTON, Del., Feb. 29, 2024 -- Prelude Therapeutics Incorporated , a clinical-stage precision oncology company, announced today that the Company will participate in the Barclays Global...
22.02.2024 - BURLINGTON, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) - Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business ...